Versartis - Improving Therapies, Improving Lives


About Versartis


Latest News


Contact Us

Versartis, Inc. is a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of endocrine disorders.

Versartis is developing new therapeutic proteins utilizing the novel half-life extension technology, XTEN. 

Partner with Us

The company is interested in exploring partnerships on our products to accelerate the development process and ensure successful commercialization. 



Versartis, Inc.
4200 Bohannon Drive
Suite 250
Menlo Park, CA 94025
(650) 963-8580